aData availability for data set 1 (Truven Health Analytics MarketScan) ended in Q1 of 2011.
bData availability for data set 2 (Optum Insight Clinformatics Data Mart) ended in Q2 of 2012.
ADT indicates androgen-deprivation therapy; CRPC, castration-resistant prostate cancer; Q, quarter.